Chronic Pain and Neuromodulation
Pain is becoming a top priority in medicine today. The majority of physician office visits are related to pain complaints. There are millions of individuals who suffer from chronic pain that cannot be treated by conventional pain management techniques. These patients may be candidates for neuromodulation stimulation, a treatment that is rapidly becoming the standard of practice for pain management.
Neuromodulation stimulation is a recognized option for 30 years and in recent years experienced an exponential and explosive growth. For the following reasons:
- Implantable hardware technology has dramatically improved in reliability and ease of use.
- Insight into the various related disease processes has greatly improved in the past decade.
- Some of the applications have reached a much broader acceptance by the physicians, the public and insurance companies.
- Some companies (i.e. Medtronic Inc, St. Jude, Boston Scientific, Cyberonics Inc.) have seen a steady growth and have established a solid presence in the market. Other companies are on the verge of entering the market with powerful products (Nevro, Spinal Modulation, Bioness)
The clinical areas of Neuromodulation are diverse and new applications are constantly being discovered. Today, the largest applications for neuro-implantable technologies include chronic pain, spasticity due to stroke or spinal cord injury, epilepsy, bladder incontinence, intractable cardiac angina, Parkinson’s disease, deafness (cochlear implants).